Literature DB >> 12733990

S3 to S3' subsite specificity of recombinant human cathepsin K and development of selective internally quenched fluorescent substrates.

Marcio F M Alves1, Luciano Puzer, Simone S Cotrin, Maria Aparecida Juliano, Luiz Juliano, Dieter Brömme, Adriana K Carmona.   

Abstract

We have systematically examined the S3 to S3' subsite substrate specificity requirements of cathepsin K using internally quenched fluorescent peptides derived from the lead sequence Abz-KLRFSKQ-EDDnp [where Abz is o -aminobenzoic acid and EDDnp is N -(2,4-dinitrophenyl)ethylenediamine]. We assayed six series of peptides, in which each position except Gln was substituted with various natural amino acids. The results indicated that the S3-S1 subsite requirements are more restricted than those of S1'-S3'. Cathepsin K preferentially accommodates hydrophobic amino acids with aliphatic side chains (Leu, Ile and Val) in the S2 site. Modifications at P1 residues also have a large influence on cathepsin K activity. Positively charged residues (Arg and Lys) represent the best accepted amino acids in this position, although a particular preference for Gly was found as well. Subsite S3 accepted preferentially basic amino acids such as Lys and Arg. A broad range of amino acids was accommodated in the remaining subsites. We further explored the acceptance of a Pro residue in the P2 position by cathepsin K in order to develop specific substrates for the enzyme. Two series of peptides with the general sequences Abz-KXPGSKQ-EDDnp and Abz-KPXGSKQ-EDDnp (where X denotes the position of the amino acid that is altered) were synthesized. The substrates Abz-KPRGSKQ-EDDnp and Abz-KKPGSKQ-EDDnp were cleaved by cathepsin K at the Arg-Gly and Gly-Ser bonds respectively, and have been shown to be specific for cathepsin K when compared with other lysosomal cysteine proteases such as cathepsins L and B and with the aspartyl protease cathepsin D.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12733990      PMCID: PMC1223542          DOI: 10.1042/BJ20030438

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  33 in total

1.  Substrate specificity of recombinant osteoclast-specific cathepsin K from rabbits.

Authors:  K Aibe; H Yazawa; K Abe; K Teramura; M Kumegawa; H Kawashima; K Honda
Journal:  Biol Pharm Bull       Date:  1996-08       Impact factor: 2.233

2.  Molecular cloning of a possible cysteine proteinase predominantly expressed in osteoclasts.

Authors:  K Tezuka; Y Tezuka; A Maejima; T Sato; K Nemoto; H Kamioka; Y Hakeda; M Kumegawa
Journal:  J Biol Chem       Date:  1994-01-14       Impact factor: 5.157

3.  Characterization of the substrate specificity of the major cysteine protease (cruzipain) from Trypanosoma cruzi using a portion-mixing combinatorial library and fluorogenic peptides.

Authors:  E D Nery; M A Juliano; M Meldal; I Svendsen; J Scharfstein; A Walmsley; L Juliano
Journal:  Biochem J       Date:  1997-04-15       Impact factor: 3.857

4.  On the size of the active site in proteases. I. Papain.

Authors:  I Schechter; A Berger
Journal:  Biochem Biophys Res Commun       Date:  1967-04-20       Impact factor: 3.575

5.  Pycnodysostosis, a lysosomal disease caused by cathepsin K deficiency.

Authors:  B D Gelb; G P Shi; H A Chapman; R J Desnick
Journal:  Science       Date:  1996-08-30       Impact factor: 47.728

6.  Specificity determinants of human cathepsin s revealed by crystal structures of complexes.

Authors:  Thomas A Pauly; Traian Sulea; Mark Ammirati; J Sivaraman; Dennis E Danley; Matthew C Griffor; Ajith V Kamath; I-K Wang; Ellen R Laird; Andrew P Seddon; Robert Ménard; Miroslaw Cygler; Virginia L Rath
Journal:  Biochemistry       Date:  2003-03-25       Impact factor: 3.162

7.  Cathepsin K, but not cathepsins B, L, or S, is abundantly expressed in human osteoclasts.

Authors:  F H Drake; R A Dodds; I E James; J R Connor; C Debouck; S Richardson; E Lee-Rykaczewski; L Coleman; D Rieman; R Barthlow; G Hastings; M Gowen
Journal:  J Biol Chem       Date:  1996-05-24       Impact factor: 5.157

8.  Proteolytic activity of human osteoclast cathepsin K. Expression, purification, activation, and substrate identification.

Authors:  M J Bossard; T A Tomaszek; S K Thompson; B Y Amegadzie; C R Hanning; C Jones; J T Kurdyla; D E McNulty; F H Drake; M Gowen; M A Levy
Journal:  J Biol Chem       Date:  1996-05-24       Impact factor: 5.157

9.  The specificity of the S1' subsite of cysteine proteases.

Authors:  R Ménard; E Carmona; C Plouffe; D Brömme; Y Konishi; J Lefebvre; A C Storer
Journal:  FEBS Lett       Date:  1993-08-09       Impact factor: 4.124

10.  Human cathepsin O2, a novel cysteine protease highly expressed in osteoclastomas and ovary molecular cloning, sequencing and tissue distribution.

Authors:  D Brömme; K Okamoto
Journal:  Biol Chem Hoppe Seyler       Date:  1995-06
View more
  12 in total

1.  Cyclic, linear, cycloretro-isomer, and cycloretro-inverso peptides derived from the C-terminal sequence of bradykinin as substrates or inhibitors of serine and cysteine proteases.

Authors:  Aurelio Resende Lima; Luiz Juliano; Maria Aparecida Juliano
Journal:  Protein J       Date:  2004-05       Impact factor: 2.371

2.  Computational predictions of cysteine cathepsin-mediated fibrinogen proteolysis.

Authors:  Meghan C Ferrall-Fairbanks; Dayne M West; Simone A Douglas; Rodney D Averett; Manu O Platt
Journal:  Protein Sci       Date:  2017-12-28       Impact factor: 6.725

3.  Structural determinants of limited proteolysis.

Authors:  Marat D Kazanov; Yoshinobu Igarashi; Alexey M Eroshkin; Piotr Cieplak; Boris Ratnikov; Ying Zhang; Zhanwen Li; Adam Godzik; Andrei L Osterman; Jeffrey W Smith
Journal:  J Proteome Res       Date:  2011-07-08       Impact factor: 4.466

4.  Predictive models of protease specificity based on quantitative protease-activity profiling data.

Authors:  Gennady G Fedonin; Alexey Eroshkin; Piotr Cieplak; Evgenii V Matveev; Gennady V Ponomarev; Mikhail S Gelfand; Boris I Ratnikov; Marat D Kazanov
Journal:  Biochim Biophys Acta Proteins Proteom       Date:  2019-07-19       Impact factor: 3.036

5.  Cathepsin K: a cysteine protease with unique kinin-degrading properties.

Authors:  Emmanuel Godat; Fabien Lecaille; Claire Desmazes; Sophie Duchêne; Enrico Weidauer; Paul Saftig; Dieter Brömme; Christophe Vandier; Gilles Lalmanach
Journal:  Biochem J       Date:  2004-11-01       Impact factor: 3.857

6.  Molecular dynamics simulations of the catalytic pathway of a cysteine protease: a combined QM/MM study of human cathepsin K.

Authors:  Shuhua Ma; Lakshmi S Devi-Kesavan; Jiali Gao
Journal:  J Am Chem Soc       Date:  2007-10-13       Impact factor: 15.419

7.  A modeling study of aldehyde inhibitors of human cathepsin K using partial least squares method.

Authors:  M Shahlaei; A Fassihi; L Saghaie; E Arkan; A Pourhossein
Journal:  Res Pharm Sci       Date:  2011-07

Review 8.  Molecular probes for selective detection of cysteine cathepsins.

Authors:  Kelton A Schleyer; Lina Cui
Journal:  Org Biomol Chem       Date:  2021-07-21       Impact factor: 3.890

9.  Highly sensitive and adaptable fluorescence-quenched pair discloses the substrate specificity profiles in diverse protease families.

Authors:  Marcin Poreba; Aleksandra Szalek; Wioletta Rut; Paulina Kasperkiewicz; Izabela Rutkowska-Wlodarczyk; Scott J Snipas; Yoshifumi Itoh; Dusan Turk; Boris Turk; Christopher M Overall; Leszek Kaczmarek; Guy S Salvesen; Marcin Drag
Journal:  Sci Rep       Date:  2017-02-23       Impact factor: 4.379

10.  Dissecting the active site of the collagenolytic cathepsin L3 protease of the invasive stage of Fasciola hepatica.

Authors:  Ileana Corvo; Anthony J O'Donoghue; Lucía Pastro; Natalia Pi-Denis; Alegra Eroy-Reveles; Leda Roche; James H McKerrow; John P Dalton; Charles S Craik; Conor R Caffrey; José F Tort
Journal:  PLoS Negl Trop Dis       Date:  2013-07-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.